Sign In  |  Register  |  About Corte Madera  |  Contact Us

Corte Madera, CA
September 01, 2020 10:27am
7-Day Forecast | Traffic

  • Search Hotels in Corte Madera

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Gsk Plc ADR (NY: GSK )

36.88 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Gsk Plc ADR

< Previous 1 2
...
22 23 24 25 26 27 28 29 30
...
35 36 Next >
GlaxoSmithKline: Q4 Earnings Insights
  GlaxoSmithKline (NYSE:GSK) reported its Q4 earnings results on Wednesday, February 9, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Glaxo's Q4 Pharma Sales Jump 20% Boosted By COVID-19 Treatment; Prepares For Spin-Off
GlaxoSmithKline Plc's (NYSE: GSK) turnover was  
Via Benzinga
Earnings Scheduled For February 9, 2022
Companies Reporting Before The Bell • Equinor (NYSE:EQNR) is projected to report quarterly earnings at $0.63 per share on revenue of $25.05 billion. 
Via Benzinga
Immunome Shares Seesaw After COVID-19 Antibody Cocktail Works Against Live Omicron Virus
Immunome Inc (NASDAQ: IMNM) shares rose before falling after reporting results from testing its experimental three-antibody cocktail  
Via Benzinga
A Look Into GlaxoSmithKline's Price Over Earnings
  
Via Benzinga
Key Events This Week: All Eyes On The CPI
After what DB's Jim Reid describes as 
Via Talk Markets
Watch for Continued Gains in Shares of GlaxoSmithKline PLC (GSK)
Via Investor Brand Network
A News Blizzard
Markets are still down despite very encouraging news in January when 467,00 new hires got jobs. 
Via Talk Markets
Sanofi Records Q4 Topline, Bottomline Growth As Blockbuster Eczema Drug Soars
Sanofi SA's (NASDAQ: SNY)  
Via Benzinga
GSK To Get $1.25B As Settlement For HIV Treatment Drug Patent Row With Gilead
GlaxoSmithKline plc (NYSE: GSK) has settled a patent dispute between ViiV Healthcare and Gilead Sciences Inc (NASDAQ: GILD). 
Via Benzinga
World Markets News for Tuesday
Exxon is splitting into 3 with its new restructuring move: upstream; chemicals; and low-carbon. 
Via Talk Markets
FDA Approves First Injectable For HIV Pre-Exposure Prevention - GSK, Pfizer Backed Treatment
The FDA has approved ViiV Healthcare's Apretude (cabotegravir extended-release injectable suspension 
Via Benzinga
Panic reversal
Crude oil inventories turned out to be fuller than expected, helping reduce the oil price rise. 
Via Talk Markets
10 Stocks to Buy That Could Make You a Millionaire in 2022
After this past year, it's going to be hard to find stocks to buy to make you a millionaire in 2022. Here are 10 that might do the trick. 
Via InvestorPlace
Markets Fears
Today markets dropped precipitously over fear of a Ukrainian invasion and higher interest rates and inflation. 
Via Talk Markets
FDA Clears Lyell Immunopharma' LYL132 Trial For Solid Tumors
The FDA has cleared Lyell Immunopharma Inc's (NASDAQ: LYEL) Investigational New Drug (IND) application to initiate a Phase 1 trial for LYL132 in solid tumors.... 
Via Benzinga
Activist Investor Nelson Peltz's Fund Buys Stake In Unilever: FT
Trian Fund Management LP, the activist hedge fund run by Nelson Peltz, has built a stake in Unilever PLC (NYSE: UL), the Financial Times reports, citing people with direct... 
Via Benzinga
Routine Vaccination Rates in Teens and Adults Continue to Lag Behind Pre-Pandemic Levels, Follow-up Analysis Shows
From GSK
Via Business Wire
Why Jim Cramer Like NextEra Energy And Lincoln Electric?
On CNBC’s "Mad Money Lightning Round," Jim Cramer said NextEra Energy, Inc. (NYSE: 
Via Benzinga
World Markets News
Today oil and gas inventories were seen as higher than expected while potential prices fell, both bullish. 
Via Talk Markets
Wednesday File
It sound odd but the real threat to markets is slowing Chinese growth which fell to 4% in Q4 from double that earlier last year. 
Via Talk Markets
Chopped Stocks
The day's theme is sell tech and buy banks. 
Via Talk Markets
23andMe Pivoting To Clinical Research: Could That Lead To A Turnaround For The Stock?
Genetic testing company 23andMe Holding Co. (NASDAQ: ME) took the unconventional route of a SPAC deal to go public, and the stock hasn't gained much traction since it began... 
Via Benzinga
GSK Spurns $68.4B Bid From Unilever For Its Consumer Healthcare Business, Opts to Spin-off The Unit
GlaxoSmithKline rejects three purchase offers from Unilever for its Consumer Healthcare business. The U.K. pharma giant says the business is well-positioned to... 
Via Benzinga
More Serious Matters
Wall Street fell on new worries about inflation and a drop in retail sales levels. 
Via Talk Markets
Watch for Continued Gains in Shares of GlaxoSmithKline PLC (GSK)
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Shares of GlaxoSmithKline PLC (NYSE: GSK... 
Via Benzinga
WHO Recommends Glaxo, Eli Lilly Drugs For COVID-19 Treatment Amid Omicron Surge
An expert panel at the World Health Organization (WHO) recommended the use of treatments developed by Eli Lilly And Co (NYSE: LLY) and GlaxoSmithKline Plc... 
Via Benzinga
Two Curses Of The Current Year
The good news on inflation after this week's shocker is that December wholesale prices only rose 0.2%. 
Via Talk Markets
GSK, Vir Biotech File For Emergency Use Nod For Intramuscular Sotrovimab For COVID-19
GlaxoSmithKline plc (NYSE: GSK) and Vir Biotechnology Inc (NASDAQ: VIR) have applied to the FDA to include intramuscular (IM) administration to sotrovimab... 
Via Benzinga
Adagio's COVID-19 Antibody Has Neutralizing Activity Comparable To Other Antibodies
Adagio Therapeutics Inc (NASDAQ: ADGI) shares gain during the premarket session after recent findings showing that ADG20 has neutralization activity against the omicron... 
Via Benzinga
< Previous 1 2
...
22 23 24 25 26 27 28 29 30
...
35 36 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 CorteMadera.com & California Media Partners, LLC. All rights reserved.